iothalamic acid has been researched along with Cystic Fibrosis in 3 studies
Iothalamic Acid: A contrast medium in diagnostic radiology with properties similar to those of diatrizoic acid. It is used primarily as its sodium and meglumine (IOTHALAMATE MEGLUMINE) salts.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied the pharmacokinetics of ciprofloxacin in 12 adult males with and 12 adult males without cystic fibrosis (CF)." | 9.06 | Pharmacokinetics of ciprofloxacin in cystic fibrosis. ( Davis, RL; Heggen, L; Koup, JR; Smith, AL; Stempel, D; Weber, A; Williams-Warren, J, 1987) |
| " Eight cystic fibrosis patients and 8 healthy volunteers were recruited into a crossover pharmacokinetic study in which participants received 180 mg fexofenadine with or without 1 g probenecid twice a day." | 6.73 | Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine. ( Beringer, PM; Burckart, GJ; Hidayat, L; Liu, S; Louie, S; Rao, AP; Shapiro, B, 2008) |
| "We studied the pharmacokinetics of ciprofloxacin in 12 adult males with and 12 adult males without cystic fibrosis (CF)." | 5.06 | Pharmacokinetics of ciprofloxacin in cystic fibrosis. ( Davis, RL; Heggen, L; Koup, JR; Smith, AL; Stempel, D; Weber, A; Williams-Warren, J, 1987) |
| " Eight cystic fibrosis patients and 8 healthy volunteers were recruited into a crossover pharmacokinetic study in which participants received 180 mg fexofenadine with or without 1 g probenecid twice a day." | 2.73 | Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine. ( Beringer, PM; Burckart, GJ; Hidayat, L; Liu, S; Louie, S; Rao, AP; Shapiro, B, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, S | 1 |
| Beringer, PM | 2 |
| Hidayat, L | 2 |
| Rao, AP | 2 |
| Louie, S | 1 |
| Burckart, GJ | 1 |
| Shapiro, B | 1 |
| Heed, A | 1 |
| Zheng, L | 1 |
| Owens, H | 1 |
| Benitez, D | 1 |
| Davis, RL | 1 |
| Koup, JR | 1 |
| Williams-Warren, J | 1 |
| Weber, A | 1 |
| Heggen, L | 1 |
| Stempel, D | 1 |
| Smith, AL | 1 |
3 trials available for iothalamic acid and Cystic Fibrosis
| Article | Year |
|---|---|
Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, | 2008 |
GFR estimates using cystatin C are superior to serum creatinine in adult patients with cystic fibrosis.
Topics: Biomarkers; Creatinine; Cystatin C; Cystic Fibrosis; Female; Glomerular Filtration Rate; Humans; Iot | 2009 |
Pharmacokinetics of ciprofloxacin in cystic fibrosis.
Topics: Administration, Oral; Adolescent; Adult; Chromatography, High Pressure Liquid; Ciprofloxacin; Cystic | 1987 |